Balchem Corp.

Is Balchem Corp. overvalued or undervalued?

As of October 17, 2025, Balchem Corp. is fairly valued with a P/E ratio of 40 and has underperformed the S&P 500 over the past year with a return of -14.21%, although it recently outperformed the index in the last week with a return of 2.04%.

As of 17 October 2025, Balchem Corp. moved from expensive to fair in its valuation grade. The company appears to be fairly valued based on its current metrics. The P/E ratio stands at 40, while the EV to EBITDA ratio is 23.46, and the Price to Book Value is 4.50.<BR><BR>In comparison to its peers, Balchem Corp. has a P/E of 36.79, which is higher than The J. M. Smucker Co. at 23.79 and lower than Conagra Brands, Inc. at 8.91. The return comparison shows that Balchem Corp. has underperformed against the S&P 500 over the past year, with a return of -14.21% compared to the S&P 500's 14.08%, but it has outperformed in the last week with a return of 2.04% against 1.70% for the index.

Is Balchem Corp. technically bullish or bearish?

As of September 12, 2025, Balchem Corp. is in a bearish trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -4.02% compared to 12.22%.

As of 12 September 2025, the technical trend for Balchem Corp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength, indicated by the daily moving averages and the weekly KST being bearish. The MACD shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting mixed signals across time frames. The Bollinger Bands are also bearish on both weekly and monthly charts. <BR><BR>In terms of performance, Balchem has underperformed the S&P 500 across multiple periods, with a year-to-date return of -4.02% compared to the S&P 500's 12.22%, and a one-year return of -11.13% versus 17.14%.

How big is Balchem Corp.?

As of Jun 18, Balchem Corp. has a market capitalization of $5.21 billion, with recent net sales of $964.54 million and a net profit of $136.54 million.

Market Cap: As of Jun 18, Balchem Corp. has a market capitalization of 5,210.17 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Balchem Corp. reported net sales of 964.54 million and a net profit of 136.54 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,149.91 million and total assets of 1,605.05 million.

What does Balchem Corp. do?

Balchem Corporation develops and markets specialty performance ingredients for various sectors, including food, pharmaceuticals, and industrial applications. As of March 2025, it reported net sales of $251 million and a market cap of $5.21 billion.

Overview: <BR>Balchem Corporation is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various markets, including food, nutritional, feed, pharmaceutical, medical sterilization, and industrial, operating within the FMCG industry and classified as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 251 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 37 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 5,210.17 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 40.00 <BR>Dividend Yield: 46.14% <BR>Debt Equity: 0.12 <BR>Return on Equity: 11.35% <BR>Price to Book: 4.31<BR><BR>Contact Details: <BR>Address: 52 Sunrise Park Rd, NEW HAMPTON NY: 10958-4703 <BR>Tel: 1 845 3265600 <BR>Fax: 1 845 3265742 <BR>Website: http://www.balchem.com/

Should I buy, sell or hold Balchem Corp.?

Who are in the management team of Balchem Corp.?

As of March 2022, Balchem Corp.'s management team includes Mr. Theodore Harris as Chairman, President, and CEO, with Dr. John Televantos serving as Lead Independent Director, alongside Independent Directors Mr. Paul Coombs, Mr. David Fischer, Mr. Daniel Knutson, and Ms. Joyce Lee.

As of March 2022, the management team of Balchem Corp. includes Mr. Theodore Harris, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, Dr. John Televantos is the Lead Independent Director. The board also comprises several Independent Directors: Mr. Paul Coombs, Mr. David Fischer, Mr. Daniel Knutson, and Ms. Joyce Lee.